Amgen recently had two big wins. First, after years of wrangling with the FDA, they finally won approval for their innovative osteoporosis drug, Evenity. Second, Amgen launched Evenity at a price ...

EVENITY has been studied for its potential to reduce the risk of fractures in an extensive global Phase 3 program that included two large fracture trials comparing EVENITY to either placebo or active ...

The Food and Drug Administration (FDA) has approved Evenity (romosozumab-aqqg; Amgen) injection for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a ...

The U.S. Food and Drug Administration has approved a drug treatment specifically for postmenopausal women with a high risk of breaking bones. Doses are taken in two back-to-back injections ...

The US Food and Drug Administration has approved a new treatment for osteoporosis in postmenopausal women who are at high risk of bone fractures. The FDA announced Tuesday that the drug, called ...

1. Evenity, a monthly injection, is approved to treat osteoporosis is postmenopausal women at high risk of bone fracture. 2. Dovato is a two-drug, fixed-dose complete regimen for HIV patients who have ...

(Reuters) - Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12-month course of injections. The U.S. Food and Drug ...

Amgen, Inc. AMGN and its partner UCB announced that the FDA has approved Evenity (romosozumab-aqqg) for treating osteoporosis in postmenopausal women at high risk of fracture. Evenity is the first and ...

Doctors prescribe Evenity (romosozumab-aqqg) for treating postmenopausal osteoporosis. The drug falls under Medicare Part B coverage because a healthcare professional must administer the injection. As ...

DEAR DR. ROACH: I’ve been taking calcium supplements for many years to assist in strengthening my bones. I’m 74, weigh less than 95 pounds and stand 5 feet tall. I’m on the verge of osteoporosis, and ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California in this October 21, 2013 file photo.